Bailard’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.61M Sell
11,001
-1,466
-12% -$305K 0.05% 222
2026
Q1
$2.63M Buy
12,467
+1,903
+18% +$410K 0.06% 206
2025
Q4
$2.17M Sell
10,564
-1,996
-16% -$376K 0.05% 224
2025
Q3
$1.97M Buy
12,560
+6,476
+106% +$1M 0.04% 241
2025
Q2
$1.02M Sell
6,084
-265
-4% -$39.3K 0.02% 320
2025
Q1
$875K Buy
6,349
+337
+6% +$43K 0.02% 330
2024
Q4
$711K Buy
6,012
+177
+3% +$20.7K 0.02% 374
2024
Q3
$645K Buy
5,835
+414
+8% +$43.3K 0.02% 417
2024
Q2
$533K Buy
5,421
+128
+2% +$13K 0.01% 438
2024
Q1
$592K Buy
5,293
+2,113
+66% +$228K 0.02% 428
2023
Q4
$321K Buy
+3,180
New +$316K 0.01% 544
2021
Q3
Sell
-3,705
Closed -$212K 714
2021
Q2
$212K Sell
3,705
-560
-13% -$32.7K 0.01% 659
2021
Q1
$259K Sell
4,265
-642
-13% -$35.4K 0.01% 568
2020
Q4
$263K Buy
4,907
+519
+12% +$26.9K 0.01% 470
2020
Q3
$206K Buy
+4,388
New +$225K 0.01% 461
2015
Q4
Sell
-25,887
Closed -$1.99M 223
2015
Q3
$1.99M Buy
25,887
+905
+4% +$75.6K 0.31% 54
2015
Q2
$2.09M Sell
24,982
-650
-3% -$57.4K 0.32% 57
2015
Q1
$2.31M Buy
25,632
+20,358
+386% +$1.75M 0.32% 52
2014
Q4
$426K Hold
5,274
0.06% 161
2014
Q3
$395K Sell
5,274
-646
-11% -$47K 0.06% 149
2014
Q2
$406K Sell
5,920
-50
-0.8% -$3.4K 0.06% 146
2014
Q1
$418K Sell
5,970
-742
-11% -$51.6K 0.07% 146
2013
Q4
$448K Sell
6,712
-523
-7% -$32K 0.07% 144
2013
Q3
$377K Sell
7,235
-41,015
-85% -$2.08M 0.07% 166
2013
Q2
$2.28M Buy
+48,250
New +$2.2M 0.41% 50

Other funds holding CAH

Bailard's CAH Position: Q2 2026 in Review

Bailard reduced its Cardinal Health (CAH) stake by 12% in Q2 2026, selling an estimated $305K and leaving 11,001 shares worth $2.61M. The position accounts for 0.05% of the portfolio, ranked #222.

Bailard first reported a position in CAH in Q2 2013 and has held it in 25 quarters since. The position peaked at $2.63M in Q1 2026. 1,492 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Bailard held 11,001 shares of Cardinal Health worth $2.61M as of Q2 2026.
  • Bailard sold 1,466 Cardinal Health shares in Q2 2026, an estimated $305K.
  • Cardinal Health made up 0.05% of Bailard's portfolio in Q2 2026, its #222 holding.
  • Bailard first reported a position in Cardinal Health in Q2 2013 and has held it in 25 quarters since.
  • Bailard's Cardinal Health position peaked at $2.63M in Q1 2026.
  • 1,492 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Bailard's 13F filing for Q2 2026, filed 30 Jul 2026.